Background: Insight in causes of death in demented patients may help physicians in end-of-life care. Objectives: To investigate underlying causes of death (UCD) in demented patients stratified by age, sex, dementia subtype [Alzheimer's disease (AD), vascular dementia (VaD)] and to compare them with UCD in the general population (GP). Methods: A nationwide cohort of 59,201 patients with dementia (admitted to a hospital or visiting a day clinic) was constructed [38.7 men, 81.4 years (SD 7.0)] from 2000 through 2010. UCDs were reported and compared to the GP by calculating relative risks (RRs). Results: During follow up [median follow up time 1.3 years (IQR 0.3- 3.0)], 64.2 of women and 69.3 of men died. Leading UCDs were dementia (17.5 in men...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Background: Dementia drug development aims to modulate pathological processes that cause clinical sy...
Background: Insight in causes of death in demented patients may help physicians in end-of-life care....
Background and purpose: Dementia disorders predispose for lethal complications and decrease life exp...
OBJECTIVE: To investigate the immediate causes of death, in autopsied demented and non-demented elde...
OBJECTIVE: To investigate the last phase of dementia and the causes of death; comparing autopsy and ...
Background: Dementia is typically known for its insidious onset and slowly progressive course, but a...
Background: Dementia is typically known for its insidious onset and slowly progressive course, but a...
OBJECTIVES: The causes of death in dementia are not established, particularly in rarer dementias. Th...
OBJECTIVES: The causes of death in dementia are not established, particularly in rarer dementias. Th...
OBJECTIVES: The causes of death in dementia are not established, particularly in rarer dementias. Th...
OBJECTIVE: Our aim was to describe physicians' perceptions of the suffering of their patients who ar...
INTRODUCTION:Globally, dementia is one of the leading causes of death. Given the growing elderly pop...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Background: Dementia drug development aims to modulate pathological processes that cause clinical sy...
Background: Insight in causes of death in demented patients may help physicians in end-of-life care....
Background and purpose: Dementia disorders predispose for lethal complications and decrease life exp...
OBJECTIVE: To investigate the immediate causes of death, in autopsied demented and non-demented elde...
OBJECTIVE: To investigate the last phase of dementia and the causes of death; comparing autopsy and ...
Background: Dementia is typically known for its insidious onset and slowly progressive course, but a...
Background: Dementia is typically known for its insidious onset and slowly progressive course, but a...
OBJECTIVES: The causes of death in dementia are not established, particularly in rarer dementias. Th...
OBJECTIVES: The causes of death in dementia are not established, particularly in rarer dementias. Th...
OBJECTIVES: The causes of death in dementia are not established, particularly in rarer dementias. Th...
OBJECTIVE: Our aim was to describe physicians' perceptions of the suffering of their patients who ar...
INTRODUCTION:Globally, dementia is one of the leading causes of death. Given the growing elderly pop...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Objective: To examine the relative risk and population attributable risk (PAR) of death with dementi...
Background: Dementia drug development aims to modulate pathological processes that cause clinical sy...